The Shareholders Foundation announces that an investor, who purchased shares of InnerWorkings, Inc. (NASDAQ:INWK), filed a lawsuit in the U.S. District Court for the Northern District of Illinois over alleged violations of Federal Securities Laws by InnerWorkings, Inc. (NASDAQ:INWK) in connection with certain allegedly false and misleading statements made between February 15, 2012 and November 6, 2013. InnerWorkings, Inc. (NASDAQ:INWK) net profit margin is -1.00% and weekly performance is 0.28%. On last trading day company shares ended up $7.12. Analysts mean target price for the company is $8.83. InnerWorkings, Inc. (NASDAQ:INWK) distance from 50-day simple moving average (SMA50) is -7.25%.
MBIA Inc (NYSE:MBI) saw unusually large options trading on Friday. Stock traders acquired 9,539 call options on the company, American Banking News.com reports. This is an increase of approximately 292% compared to the average daily volume of 2,435 call options. MBIA Inc. (NYSE:MBI) shares advanced 0.76% in last trading session and ended the day on $11.99. MBI return on assets is 2.00%. MBIA Inc. (NYSE:MBI) quarterly performance is 2.48%.
In a separate corporate news release, the drug’s manufacturer, Arena Pharmaceuticals Inc. (NASDAQ:ARNA) GmbH of Zofingen, Switzerland, said Friday the expanded force will enable Eisai to reach 90,000 physicians across the U.S. Arena Pharmaceuticals said in its latest annual report that it recognized $5.7 million in net sales of Belviq last year. Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) shares moved up 3.01% in last trading session and was closed at $7.19, while trading in range of $6.85 – $7.22. Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) year to date (YTD) performance is 22.91%.
MannKind Corporation (NASDAQ:MNKD) will post its first quarter 2014 quarterly earnings on Monday May 12. Analysts estimate the company will post losses of 13 cents per share for the quarter. On average, analysts expect the company to post losses of 35 cents per share for the full fiscal year and losses of 20 cents per share for the next fiscal year. MannKind Corporation (NASDAQ:MNKD) ended the last trading day at $6.22. Company weekly volatility is calculated as 3.45% and price to cash ratio as 33.90. MannKind Corporation (NASDAQ:MNKD) showed a negative weekly performance of -2.05%.
Leave a Reply